These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6310562)

  • 1. Isolation of opiate binding components by affinity chromatography and reconstitution of binding activities.
    Cho TM; Ge BL; Yamato C; Smith AP; Loh HH
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5176-80. PubMed ID: 6310562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and partial purification of solubilized active opiate receptors from toad brain.
    Ruegg UT; Cuenod S; Hiller JM; Gioannini T; Howells RD; Simon EJ
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4635-8. PubMed ID: 6270689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical separation of the agonist and antagonist forms of a mu opiate receptor?
    Jauzac P; Puget A; Meunier JC
    Life Sci; 1983; 33 Suppl 1():195-8. PubMed ID: 6319859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.
    Richards ML; Sadée W
    Eur J Pharmacol; 1985 Aug; 114(3):343-53. PubMed ID: 2998812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5'-Guanylylimidodiphosphate decreases affinity for agonists and apparent molecular size of a frog brain opioid receptor in digitonin solution.
    Mollereau C; Pascaud A; Baillat G; Mazarguil H; Puget A; Meunier JC
    J Biol Chem; 1988 Dec; 263(34):18003-8. PubMed ID: 2848020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and purification of morphine receptor by affinity chromatography.
    Cho TM; Ge BL; Loh HH
    Life Sci; 1985 Mar; 36(11):1075-85. PubMed ID: 2983166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct molecular forms of opiate binding in the frog brain.
    Puget A; Jauzac P; Meunier JC
    Life Sci; 1983; 33 Suppl 1():199-202. PubMed ID: 6319860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of the mu opiate receptor from rat brain using affinity chromatography.
    Maneckjee R; Zukin RS; Archer S; Michael J; Osei-Gyimah P
    Proc Natl Acad Sci U S A; 1985 Jan; 82(2):594-8. PubMed ID: 2982164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation and solubilization of opiate receptors by phospholipases A2.
    Rüegg UT; Cuénoud S; Fulpius BW; Simon EJ
    Biochim Biophys Acta; 1982 Mar; 685(3):241-8. PubMed ID: 6279149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of solubilized delta-opiate receptor binding sites in lipid vesicles.
    Scheideler MA; Zukin RS
    J Biol Chem; 1990 Sep; 265(25):15176-82. PubMed ID: 2168403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of the opiate receptor from rat brain.
    Bidlack JM; Abood LG; Osei-Gyimah P; Archer S
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):636-9. PubMed ID: 6264453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
    Werling LL; Puttfarcken PS; Cox BM
    Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization, solubilization and purification of an opioid receptor from the brain of the frog Rana ridibunda.
    Pascaud A; Mollereau C; Puget A; Baillat G; Mazarguil H; Meunier JC
    NIDA Res Monogr; 1986; 75():5-8. PubMed ID: 2828997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate receptor thermodynamics: agonist and antagonist binding.
    Hitzemann R; Murphy M; Curell J
    Eur J Pharmacol; 1985 Jan; 108(2):171-7. PubMed ID: 2984022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel opiate binding sites selective for benzomorphan drugs.
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of three types of opioid binding sites in rat brain in vivo.
    Rosenbaum JS; Holford NH; Richards ML; Aman RA; Sadée W
    Mol Pharmacol; 1984 Mar; 25(2):242-8. PubMed ID: 6321946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on brain opiate receptor stability in vitro: inhibition of opiate receptor binding by adenosine-5'-diphosphate.
    Brase DA
    Biochem Biophys Res Commun; 1981 Nov; 103(1):189-95. PubMed ID: 6274341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.